Yukiko Miyazaki Selected Research

Pharmaceutical Preparations

12/2021	Exploring natural microbial resources for the discovery of anti-malarial compounds.
1/2020	Generation of Novel Plasmodium falciparum NF135 and NF54 Lines Expressing Fluorescent Reporter Proteins Under the Control of Strong and Constitutive Promoters.
1/2019	Identification of Plasmodium falciparum Mitochondrial Malate: Quinone Oxidoreductase Inhibitors from the Pathogen Box.
1/2019	Identification of Alprenolol Hydrochloride as an Anti-prion Compound Using Surface Plasmon Resonance Imaging.
1/2018	Selective Cytotoxicity of Dihydroorotate Dehydrogenase Inhibitors to Human Cancer Cells Under Hypoxia and Nutrient-Deprived Conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukiko Miyazaki Research Topics

Disease

3	Malaria 01/2020 - 01/2019
2	Infections 01/2020 - 01/2019
1	Parasitic Diseases (Parasitic Disease) 12/2021
1	Gliosis 10/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2019
1	Neoplasms (Cancer) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Coronary Disease (Coronary Heart Disease) 01/2002

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 12/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2019
2	VaccinesIBA 01/2020 - 01/2020
1	Antimalarials (Antimalarial Agents)IBA 12/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 10/2020
1	Luminescent ProteinsIBA 01/2020
1	Prion ProteinsIBA 01/2019
1	AlprenololIBA 01/2019
1	PrionsIBA 01/2019
1	Recombinant ProteinsIBA 01/2019
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2019
1	pyrimidineIBA 01/2018
1	Dihydroorotate DehydrogenaseIBA 01/2018
1	SeleniumIBA 01/2002

Therapy/Procedure

1	Therapeutics 01/2019